ThermoDox(R) Liver Cancer Study Phase I Results to Be Presented at ...
ThermoDox(R) Liver Cancer Study Phase I Results to Be Presented at ILCA Conference 2008. - COLUMBIA, Md.--(BUSINESS WIRE)--CELSION CORPORATION (NASDAQ:
CLSN ...
http://biz.yahoo.com/bw/080828/20080828005108.html?.v=1...
|
News: Philips and Celsion Announce Research Agreement to Develop ...
Doxorubicin is the potent anticancer agent in ThermoDox(R). ... First, ThermoDox (R) has the potential to eliminate cancer cells that may otherwise remain ...
http://www.genengnews.com/news/bnitem.aspx?name=43636171...
|
Yakult Honsha to Commence ThermoDox(R) Development Program in ...
Yakult Honsha to Commence ThermoDox(R) Development Program in Japan. - COLUMBIA, Md.--(BUSINESS WIRE)--Celsion Corporation (NASDAQ: CLSN: Michael H.
http://biz.yahoo.com/bw/080818/20080818005092.html?.v=1...
|
Royal Phillips Electronics and Celsion Corporation Announce ...
16 Oct 2008 ... Doxorubicin is the potent anticancer agent in ThermoDox®. By using Philips’ HIFU technology to deliver targeted, localized activation ...
http://www.biospace.com/news_story.aspx?NewsEntityId=113238...
|
Philips and Celsion Announce Research Agreement to Develop New ...
Multi-year agreement will explore the potential for using ThermoDox(R) in combination with high intensity focused ultrasound to treat solid and diffuse
...
http://biz.yahoo.com/bw/081016/20081016005194.html?.v=1...
|
Definition of lyso-thermosensitive liposome doxorubicin - National ...
Synonym: heat-activated liposomal doxorubicin hydrochloride. US brand name: ThermoDox. Previous: Lymphazurin, LymphoCide, lymphokine-activated killer cells,
...
http://www.nci.nih.gov/Templates/drugdictionary.aspx?CdrID=4...
|
Summary of CELSION CORP - Yahoo! Finance
Our first drug, ThermoDox®, an encapsulation of doxorubicin, a common oncology drug, in our heat activated liposome, is in clinical studies for the ...
http://biz.yahoo.com/e/080328/cln10-k.html...
|
BioSpace - Celsion Corporation News, Search Jobs, Events
Celsion Corporation (CLN) Release: ThermoDox(R) Liver Cancer Study Phase I Results ... Yakult Honsha to Commence ThermoDox(R) Development Program in Japan
...
http://www.biospace.com/company_profile.aspx?CompanyId=3697...
|
Celsion Corporation Reports Third Quarter 2008 Financial Results ...
13 Nov 2008 ... Announced that Yakult Honsha is proceeding with its plans to initiate a clinical program in Japan to study ThermoDox ® for the treatment of ...
http://biz.yahoo.com/bw/081113/20081113005213.html?.v=1...
|
British Journal of Cancer - Tumour-targeted nanomedicines ...
(E) Stimuli-sensitive nanomedicines, such as Thermodox, can be activated (i.e. ... Thermodox, a temperature-sensitive version of liposomal doxorubicin (that
...
http://www.nature.com/uidfinder/10.1038/sj.bjc.6604483...
|
